New hope for stroke patients: mobilization of endogenous stem cells

Borlongan, Cesar V.; Hess, David C.
March 2006
CMAJ: Canadian Medical Association Journal;3/28/2006, Vol. 174 Issue 7, p954
Academic Journal
Comments on a research focusing on the therapeutic potential of granulocyte colony-stimulating factor (G-CSF) therapy for ischemic stroke. Administration of G-CSF therapy to the patients involved in the study; Improvement in the neurologic functions of patients who received G-CSF; Contributions of the results of the study to the future of stem cell therapy for stroke.


Related Articles

  • Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. Woei-Cherng Shyu; Shinn-Zong Lin; Chau-Chin Lee; Liu, Demeral David; Hung Li // CMAJ: Canadian Medical Association Journal;3/28/2006, Vol. 174 Issue 7, p927 

    Background: Because granulocyte colony-stimulating factor (G-CSF) has anti-inflammatory and neuroprotective properties and is known to mobilize stem cells, it may be useful in the treatment of acute ischemic stroke. We sought to examine the feasibility, safety and efficacy of using G-CSF to...

  • Assessment and Explorations on the Mechanism of Neuroprotection of Patients in Ischemic Stroke by Traditional Chinese Medicine. Shen Si-yu; Fu Xiao-dong; Fei Zhen-yu // Chinese Journal of Integrative Medicine;Sep2005, Vol. 11 Issue 3, p237 

    Ischemic stroke is a common clinical emergency, with thrombolysis and neuroprotection as its cardinal treatment, and nowadays the latter is more and more stressed by stroke researchers. On the basis of pathophysiology and ischemic cascade of ischemic stroke, we now try to analyze the conceivable...

  • MES, what a mess! A modern version of Russian roulette. Ringeistein, Erich Bernd; Dittrich, Ralf // Journal of Neurology, Neurosurgery & Psychiatry;Mar2008, Vol. 79 Issue 3, p238 

    The author reflects on the article about the association of ischaemic lessions with microembolic signals (MES) by Y. Iguchi and colleagues. He mentions that a proportion of acute stroke patients with MES detected 48 hours after stroke onset demonstrates a high risk of additional consecutive...

  • A validation study using a modified version of Postural Assessment Scale for Stroke Patients: Postural Stroke Study in Gothenburg (POSTGOT).  // Journal of NeuroEngineering & Rehabilitation (JNER);2011, Vol. 8 Issue 1, p57 

    The article discusses a validation study which was aimed to assess intrarater and interrater reliability using a modified version of Postural Assessment Scale for Stroke Patients (PASS), in the acute phase after their first event of stroke. The study used Spearman's rank correlation, Kappa...

  • Effect of Time of Day for Urinary Catheter Removal on Voiding Behaviors in Stroke Patients. Gross, Jan Coleman; Hardin-Fanning, Frances; Kain, Mary; Faulkner, Elizabeth A.; Goodrich, Stacey // Urologic Nursing;Jun2007, Vol. 27 Issue 3, p231 

    The article presents a study aimed to compare the effect of urinary catheter removal in stroke patients at seven in the morning, with removal at 10 in the evening on the amount of the first void, the length of time to first void after catheter removal, and the number of subjects requiring...

  • Dual therapy after stroke to prevent recurrence. Kirchner, Jeff; Russell, John J. // Patient Care;Aug2006, Vol. 40 Issue 8, p59 

    The article discusses a study by P. H. Halkes and colleagues on dual therapy for secondary stroke prevention, published in the 2006 issue of "Lancet." The study randomized 2700 patients to aspirin with or without dipyridamole following a minor stroke or transient ischemic attack. The primary...

  • Transient ischaemic attacks: time to wake up. Rothwell, Peter M. // Heart;Aug2007, Vol. 93 Issue 8, p893 

    The article discusses transient ischaemic attacks. The author focuses on the high predictability of the risk of stroke after a transient ischaemic attack (TIA) or minor stroke. Emergency investigation and treatment are researched for primary prevention strategies. Further trials are required for...

  • AXIS 2 Clinical Outcomes No Different Than Placebo. Buckley, Rita // MD Conference Express; 

    The article focuses on the promising drug AX200 that fulfilled Stroke Therapy Academic Industry Roundtable (STAIR) and European Stroke Organization recommendations. It presents the results of Treatment of Ischemic Stroke Phase 3 trial by AX200 which shows no difference in clinical outcome or...

  • Documented Effects of a Therapy For Stroke Survivors.  // HealthFacts;Jul2000, Vol. 25 Issue 7, p4 

    Reports on the findings of a study on the possibility that stroke victims can regain the use of an afflicted arm with a technique called constraint-induced movement therapy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics